The article, “The Diversity of Hornets in the Genus Vespa (Hymenoptera: Vespidae; Vespinae); Their Importance and Interceptions in the United States,” is the work of three entomologists: lead author Allan Smith-Pardo, U.S. Department of Agriculture Animal and Plant Health Inspection Service (APHIS); and co-authors James Carpenter of the American Museum of Natural History's Division of Invertebrate Zoology, and Lynn Kimsey, director of the Bohart Museum of Entomology and professor of entomology at UC Davis.
North America's first known colony of the Asian giant hornet, Vespa mandarinia, was detected and destroyed in September 2019 on Vancouver Island, British Columbia. A single V. mandarinia was found dead in Blaine, Wash., in December 2019.
“Hornet species identification can be sometimes difficult because of the amount of intraspecific color and size variation,” the authors wrote in their abstract. “This has resulted in many species-level synonyms, scattered literature, and taxonomic keys only useful for local populations. We present a key to the world species, information on each species, as well as those intercepted at United States ports of entry during the last decade.”
The journal article includes images of the 22 species and some previously described subspecies. The key should help state and federal officials identify the Vespa species, the authors said. Beekeepers, farmers and ecologists and others on the lookout for the Asian giant hornet can also benefit from the key.
In the USDA-funded research, the trio combed through scientific literature and museum collections to separate the species. They list their sources and offer insights on the distribution of each hornet, and a discussion.
The Asian giant hornet's distribution is India, Sri Lanka, Bhutan, Nepal, Myanmar, Thailand, Laos, Vietnam, Malaysia, Malaya, China, Hong Kong, Taiwan, eastern Russia, Korea, Japan (including Ryukyus), the authors wrote.
The Bohart Museum of Entomology, home of a global collection of nearly eight million insect specimens, houses 20 specimens of V. mandarinia. The largest one, a queen, measures about an inch and a half long, Kimsey said.
“Insects introduced in the United States often come in cargo boxes from Asia to U.S. ports, establish colonies, and expand their range,” she said.
The only known European hornet to colonize the United States is Vespa crabro, introduced on the East Coast in the 1800s. “It is now fully established in the southeastern U.S,” Kimsey said. “A decade or more ago, there was a colony of another species, Vespa asiatica, reported near the Port of Long Beach but nothing ever came of that.”
What's next for the research team? "We will be continuing to create online identification tools and a detailed website," Kimsey said.
"From 2010 to 2018, there have been close to 50 interceptions of Vespa (hornets) and Vespula (yellow jackets (Vespula) at U.S. ports of entry. Little less than half of those interceptions were hornets. The Vespa species intercepted include V. bellicosa, V. crabro, V. orientalis, V. mandarinia, and V. tropica. One of the interceptions of significance was an entire nest of V. mandarinia containing live brood and pupae that was sent via express courier from Asia. All species of Vespa, except V. crabro, which is already introduced into the eastern United States, are considered of quarantine importance by the USDA-APHIS."
A website, Invasive Hornets, part of a cooperation between the USDA, Animal Plant Health Inspection Service (APHIS), Plant Protection and Quarantine (PPQ) and the University of Georgia, is taking shape. According to the journal article: "This website contains more than 1,000 stacked, high-quality images of all the species and most of the races of the genus Vespa. It is important to have the resources for the identification and prevention of introduction of non-native species and to understand the potential effects of invasive hornets in our ecosystems. Hornets are dangerous for the beekeeping industry because they can alter pollination in agriculture and disrupt the beekeeping industry, as well as create public health and safety problem."
The authors credited senior museum scientists Christine Lebeau of the American Museum of Natural History and Steve Heydon of the Bohart Museum of Entomology “for helping to process the loan of Vespa material.” Mary Burns of the National Identification Services (NIS) of the USDA-APHIS- Plant Protection and Quarantine (PPQ) provided information about the number of interceptions of Vespa at U.S. ports of entry.
In an article posted in Entomology Today, science writer-educator Leslie Mertz wrote that the team is "building a publicly available, online adjunct to the newly published key that uses menus of distinguishing characteristics, as well as illustrations and photographs. They hope to have the online key up and running in 2021.”
Entomology Today publication, "Big, Beautiful, and Confusing: Deciphering the True Hornets"
ASD, which impacts the nervous system, affects 1 percent of the U.S. population or 62.2 million globally. An estimated 64 percent and 91 percent of the population are at risk genetically.
The researchers' latest paper, “Maternal Glyphosate Exposure Causes Autism-Like Behaviors in Offspring through Increased Expression of Soluble Epoxide Hydrolase,” appears in the current edition of the Proceedings of the National Academy of Sciences (PNAS). Glyphosate is a broad-spectrum systemic herbicide and crop desiccant used to kill broadleaf weeds and grasses that compete with agricultural crops.
“In the research of autism, brain-gut-microbiota axis plays a key role in ASD from human studies,” said lead researcher and neurobiologist Kenji Hashimoto of the Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. “Accumulating evidence suggests abnormal composition of gut microbiota in subjects with autism. In this study, we found abnormal composition of gut microbiota in offspring after maternal glyphosate exposure. Thus, exposure of glyphosate during pregnancy may cause abnormal composition of gut microbiota in offspring, resulting in the risk for autism.'
The drug discovered in the Hammock lab inhibits sEH, a natural enzyme that regulates epoxy fatty acids, “which control blood pressure, fibrosis, immunity, tissue growth, depression, pain and inflammation to name a few processes,” said co-author Hammock, a distinguished professor with a joint appointment in the UC Davis Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center. Human clinical trials underway to see if the non-addictive drug relieves chronic pain.
“It is critical to appreciate that mouse models are not absolutely predictive of the human situation,” Hammock said.“Similarly, maternal immune stress is simply a model that gives behavioral changes in the offspring. That said, it is a relevant model of abnormalities in mental development in the offspring. This is a widely used model of the effect of maternal stress on the next generation that has been established in many species, including nonhuman primates. Sadly, maternal stress was shown tightly associated with the mental state of human children as well.”
“Such studies are important to generate hypotheses of environmental risk,” said Hammock, who meshes his expertise in chemistry, toxicology, biochemistry and entomology, in his 50-year research to find a non-addictive drug to control chronic pain. “Because we only saw maternal immune stress at exceptionally high doses of glyphosate, our data fail to support the hypothesis that glyphosate exposure causes autism with expected dietary, environmental or even occupational exposure.”
The research drew financial support from the Japan Society for the Promotion of Science (to Hashimoto); and the National Institute of Environmental Health Sciences (NIEHS) River Award (to Hammock), and NIEHS Superfund Program (to Hammock). Hammock has directed the UC Davis Superfund Program for nearly four decades.
The Hashimoto-directed Chiba group has shown that these drug candidates prevent and even reverse a variety of chronic diseases of the central nervous system in mice and human cells including ASD like behaviors.
The 16 co-authors include Hammock lab researchers Jun Yang, Sung Hee Hwang and Debin Wan.
Yang said that the researchers “hypothesized that the role of the sEH is important in the pathogenesis of ASD in offspring after maternal glyphosate exposure based on our previous finding that sEH plays a key role in the development of ASD-like behavioral abnormalities in juvenile offspring after maternal immune activation (MIA), a prenatal environmental factor.”
Said Hwang: “Some epidemiological studies suggest an association between glyphosate use in agriculture and increases in autism like disorders. The doses we used in mice were so high that we fail to support glyphosate epidemiological associations between the herbicide use and the cause ASD-like behaviors.
The PNAS abstract:
“Epidemiological studies suggest that exposure to herbicides during pregnancy might increase risk for autism spectrum disorder (ASD) in offspring. However, the mechanisms underlying the risk of ASD by herbicides such as glyphosate remain unclear. Soluble epoxide hydrolase (sEH) in the metabolism of polyunsaturated fatty acids is shown to play a key role in the development of ASD in offspring after maternal immune activation. Here, we found ASD-like behavioral abnormalities in juvenile offspring after maternal exposure to high levels of formulated glyphosate.
“Furthermore, we found increases in sEH in the prefrontal cortex (PFC), hippocampus, and striatum of juvenile offspring and oxylipin analysis showed decreased levels of epoxy-fatty acids such as 8(9)-EpETrE in the blood, PFC, hippocampus, and striatum of offspring after maternal glyphosate exposure, supporting increased activity of sEH in the offspring. Moreover, we report abnormal composition of gut microbiota and short chain fatty acids in fecal samples of juvenile offspring after maternal glyphosate exposure. Interestingly, oral administration of TPPU (an sEH inhibitor) to pregnant mothers from E5 to P21 prevented ASD-like behaviors such as social interaction deficits and increased grooming time in the juvenile offspring. These findings suggest that maternal exposure to high levels of glyphosate causes ASD-like behavioral abnormalities and abnormal composition of gut microbiota in juvenile offspring, and that increased activity of sEH might play a role in ASD-like behaviors in offspring after maternal glyphosate exposure. Therefore, sEH may represent a target for ASD in offspring after maternal stress from occupational exposure to contaminants.
“Maternal exposure to high levels of the herbicide glyphosate may increase the risk for autism spectrum disorder (ASD) in offspring; however, the underlying mechanisms remain largely unknown. Maternal glyphosate exposure during pregnancy and lactation caused ASD-like behavioral abnormalities and abnormal composition of gut microbiota in murine male offspring. Soluble epoxide hydrolase (sEH) in the brain of offspring after maternal glyphosate exposure was higher than controls. Treatment with an sEH inhibitor from pregnancy to weaning prevented the onset of ASD-like behavioral abnormalities in offspring after maternal glyphosate exposure. The glyphosate exposures used here exceed any reasonable dietary, environmental or occupational exposure, but they indicate that increased sEH plays a role in ASD-like behaviors in offspring.”
(See commentary published in journal Cancer Metastasic and Reviews at https://rdcu.be/b33IN)
“COVID-19 results in excessive inflammation and a cytokine storm caused by the human body's reaction to the SARS-CoV-2 virus,” said lead author Dipak Panigrahy, a Harvard University physician and researcher who collaborates with the Hammock laboratory.
“Controlling the body's inflammatory response to COVID-19 will likely be as important as anti-viral therapies or a vaccine,” Panigraphy said. “Stimulation of inflammation resolutions via pro-resolution lipid mediators that are currently in clinical trials for other inflammatory diseases is a novel approach to turning off the inflammation and preventing the cytokine storm caused by COVID-19.”
“We propose that this drug will alleviate the cytokine storms that occur when the immune system is overwhelmed, when the patient is battling for survival,” Panigrahy said.
The drug is an inhibitor to the soluble epoxide hydrolase (sEH) enzyme, a key regulatory enzyme involved in the metabolism of fatty acids.
Editor-in-Chief and Professor Kenneth Honn selected their commentary, “Inflammation Resolution: a Dual-Pronged Approach to Averting Cytokine Storms in COVID-19?,” as the top paper of the month. The work is based on more than 40 years of eicosanoid research from the Hammock lab and more than 40 years of eicosanoid research from the Charles Serhan lab at Harvard Medical School.
“The tremendous cell destruction caused by COVID in the lungs leads to cell debris, activating a series of events leading to the cytokine storm and mortality,” Panigrahy said. “Controlling inflammation is key to resolving any intense infection, and thus, desired treatments should modulate and particularly resolve inflammation.”
“A rapid immune response is critical to controlling this virus,” Panigrahy emphasized.
“We believe it holds promise to combat the inflammation involved with this disease,” said co-author Hammock, a UC Davis distinguished professor who holds a joint appointment with the Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center. “It hit me in March that what we really need to do is not so much block cytokines as to move upstream to modulate them and resolve them rather than block inflammation.”
“We can increase the concentration of natural pro-resolving mediators termed EETs which act on a biological system to produce other pro-resolution mediators which modulate inflammation and actively resolve the process,” explained Hammock, who founded the Davis-based company EicOsis Human Health LLC, to bring the inhibitor to human clinical trials, which are underway in Texas.
“It is this resolution of inflammation and the subsequent repair that is critical to restore patient health,” said Serhan, whose studies with collaborator Sime show that immune resolution and repair are active processes in the lungs and other tissues. What drives the process, Serhan said, is the production of specific pro-resolving agents (SPMs).
Puch, who did research at the National Institutes of Health (NIH) on acute respiratory distress syndrome (ARDS) and sepsis, said the drug should be effective in treating ARDS, which she defined as “a respiratory failure characterized by rapid onset of widespread inflammation in the lungs and common among seriously ill COVID-19 patients.”
“We think there are a series of control systems that fail to modulate the patient's response in COVID,” Cortés-Puch said. “The severe outcomes in some patients from the virus infection often are attributed to the cytokine storm, and blocking these cytokines represents a major therapeutic effort, which so far has failed. Our view is that we can move several steps upstream and control the cytokine storm not just at the level of individual cytokines and in doing so, we can encourage resolution of inflammation. In doing so, we can encourage resolution of inflammation.”
Said William Schmidt, EicOsis vice president of clinical development: “Our drug candidate has not caused any adverse effects at high doses in diabetic-hypertensive patients. Since this soluble epoxide hydrolase inhibitor acts upstream to down-regulate the eicosanoid and the cytokine storm, we are optimistic that it can help patients.” The Federal Drug Administration recently granted another EicOsis drug candidate a “fast track” status.
“In the meantime, we are looking at blood markers through time that are helping us to see the order of events leading from the original virus infection to the severe organ damage and cytokine storm that occurs in the most severe cases,” said Cindy McReynolds, a UC Davis doctoral student in pharmacology/toxicology, and EicOsis project manager.
Hammock said the UC Davis team began researching cytokine storms 16 years ago in projects based on the thesis of former doctoral student Kara Schmelzer. Now the UC Davis and Harvard scientists are targeting COVID-19.
Said Hammock: “In March, Cindy, Irene and I worked on a grant proposal with a group of scientists from the European Union to combine an anti-viral agent with an anti-inflammatory agent.”
“It hit me at that time,” Hammock reiterated, “that what we really need to do is not so much block cytokines as to move upstream to modulate them and resolve rather than block inflammation. We are lucky to have been working on such a resolving agent at UC Davis for decades.”
Other co-authors of the paper are Molly Gilligan and Allison Gartung of the Panigrahy lab; Sui Huang of the Institute for Systems Biology, Seattle; and Richard Phipps, independent scholar, Richmond, Va.
Much of the research was funded by NIH grants, including a National Institute of Environmental Health Science (River Award) to Hammock. The Panigrahy laboratory is generously supported by the Credit Unions Kids at Heart Team; the C.J. Buckley Pediatric Brain Tumor Fund; and the Joe Andruzzi Foundation.
Severe coronavirus disease (COVID-19) is characterized by pulmonary hyper-inflammation and potentially life-threatening “cytokine storms”. Controlling the local and systemic inflammatory response in COVID-19 may be as important as anti-viral therapies. Endogenous lipid autacoid mediators, referred to as eicosanoids, play a critical role in the induction of inflammation and pro-inflammatory cytokine production. SARS-CoV-2 may trigger a cell death (“debris”)-induced “eicosanoid storm”, including prostaglandins and leukotrienes, which in turn initiates a robust inflammatory response. A paradigm shift is emerging in our understanding of the resolution of inflammation as an active biochemical process with the discovery of novel endogenous specialized pro-resolving lipid autacoid mediators (SPMs), such as resolvins. Resolvins and other SPMs stimulate macrophage-mediated clearance of debris and counter pro-inflammatory cytokine production, a process called inflammation resolution. SPMs and their lipid precursors exhibit anti-viral activity at nanogram doses in the setting of influenza without being immunosuppressive. SPMs also promote anti-viral B cell antibodies and lymphocyte activity, highlighting their potential use in the treatment of COVID-19. Soluble epoxide hydrolase (sEH) inhibitors stabilize arachidonic acid-derived epoxyeicosatrienoic acids (EETs), which also stimulate inflammation resolution by promoting the production of pro-resolution mediators, activating anti-inflammatory processes, and preventing the cytokine storm. Both resolvins and EETs also attenuate pathological thrombosis and promote clot removal, which is emerging as a key pathology of COVID-19 infection. Thus, both SPMs and sEH inhibitors may promote the resolution of inflammation in COVID-19, thereby reducing acute respiratory distress syndrome (ARDS) and other life-threatening complications associated with robust viral-induced inflammation. While most COVID-19 clinical trials focus on “anti-viral” and “anti-inflammatory” strategies, stimulating inflammation resolution is a novel host-centric therapeutic avenue. Importantly, SPMs and sEH inhibitors are currently in clinical trials for other inflammatory diseases and could be rapidly translated for the management of COVID-19 via debris clearance and inflammatory cytokine suppression. Here, we discuss using pro-resolution mediators as a potential complement to current anti-viral strategies for COVID-19.
Robinson, who graduated from UC Davis in 1978 with dual degrees in mechanical and aeronautical engineering, saw Earth from outer space four times during NASA shuttle missions, including the 2005 Space Shuttle Discovery.
“Our Aggienaut (alumni-turned-astronaut) will be asking questions, and we're encouraging others to follow suit and ask questions, too,” said Leal, a fellow of the National Academy of Inventors and a member of the Department of Molecular and Cellular Biology faculty. He is a former chair of the UC Davis Department of Entomology.
“We've assembled another panel of experts for viewers to address their questions and concerns,” said Leal, whose peers have honored him for his research, teaching and public service.
The COVID-19 Symposium, https://bit.ly/2A2Qd8a, will be streamed via ZOOM and YouTube on Thursday, May 14 from 1:30 to 4:30 p.m. Registration is free.
Janet Napolitano, president of the University of California system, will deliver the welcoming address.
Among the panelists: Dr. David Lubarsky, vice chancellor of Human Health Sciences and chief executive officer, UC Davis Health, Dr. Allison Brashear, dean of the School of Medicine, UC Davis, Dr. Emanuel Maverakis, professor of dermatology and Immunology, UC Davis School of Medicine, and Dr. Atul Malhotra, professor of medicine, Pulmonology and Critical Care, UC San Diego Health.
The questions will include:
- Can our pets place us at risk for contracting the coronavirus?
- Can we get the virus through sexual transmission?
- Can COVID-19 survivors get secondary infections?
- What research is underway on COVID-19 therapies, management and testing?
For registration, access https://bit.ly/2A2Qd8a. Registrants can post advance questions and also ask questions online during the symposium.
The first symposium, with a welcoming address by UC Davis Chancellor Gary May, spotlighted the cutting-edge expertise of physicians, researchers, and a recovering COVID-19 patient. It is online at https://bit.ly/2VurK3Z. It drew viewers from 10 countries and the comment “I just wanted to thank you! You are my heroes.”
“This give me a sense of hope and calmed my anxiety like nothing else,” letter writer Kim Allen continued. “To hear people, real doctors and scientists who are so knowledgeable talk about what is going on and why, is so appreciated. We need to know what we are contending with to fight it and be safe. You are all so much appreciated!”
(Editor's Note: At the first UC Davis-based COVID-19 virtual seminar, UC Davis distinguished professor James R. Carey of the UC Davis Department of Entomology and Nematology delivered a presentation on “Actuarial Perspectives on the COVID-19 Pandemic.” The updated presentation is at https://youtu.be/aid69khJftU.)
“It's no more likely to sting and kill a human than a honey bee,” said Kimsey, a two-term past president of the International Society of Hymenopterists, an organization that studies bees, wasps, ants, and sawflies.
“Actually it's less likely, as honey bee venom packs quite a punch and it is exclusively designed to defend against vertebrates,” she said.
“The colony everyone is hyperventilating over was actually found on Vancouver Island, British Columbia, last September when it was destroyed and then a single, dead hornet was found in December in Blaine, Wash.,” Kimsey said. “There is no evidence that there are any more hornets in the vicinity of Vancouver or anywhere else on the West Coast.”
A colony of the Asian giant hornet (AGH), Vespa mandarinia, was found and destroyed Sept. 18, 2019 in Nanaimo, Vancouver Island, and the single dead hornet was found Dec. 8, 2019 in Blaine.
These were the first detections of this species in North America, but there may be more, according to the Washington State Department of Agriculture (WSDA). Beekeepers have reported “observations” (which may or may not be the same species) dating back to October 2019, WSDA says.
Twenty Asian giant hornet (AGH) specimens are housed in the Bohart Museum of Entomology, home of a global collection of nearly 8 million species. The largest one, a queen, measures about an inch and a half long, Kimsey said.
Meanwhile, entomologists are bemoaning the name, "murder hornet" and the sensationalism and fear-mongering ensuing.
“Some poorly-worded media reports about Asian giant hornets have triggered a veritable avalanche of nonsense online, but I can help set the record straight," wrote senior museum scientist and hymenopterist Douglas Yanega of the UC Riverside Entomology Research Museum.
“One colony was found and exterminated in Nanaimo on Vancouver Island in September of 2019, with a few sightings associated,” Yanega wrote. “One wasp believed to be from that colony was found--dead--on the U.S. side of the border near Nanaimo in December. Right now, all the authorities are doing is asking people to keep their eyes peeled JUST IN CASE there were queens that escaped the destruction of the Nanaimo nest, and established their own nests nearby. I was one of the authorities brought in to consult on this case, and to my knowledge there have not been any sightings in 2020 that would suggest the eradication attempt was unsuccessful. Put bluntly, as far as we know, there are no Asian giant hornets alive in either the U.S. or Canada as of 2020, and if there are, then they would be in the immediate vicinity of Vancouver Island (about a 50 mile radius or so).”
Said Kimsey: “A decade or more ago there was a colony of another species, Vespa asiatica, reported near the Port of Long Beach but nothing ever came of that either. A European species, Vespa crabro, was introduced into the East Coast perhaps a century ago and it is now fully established in the southeastern U.S.”
Kimsey says insects often come in cargo boxes from Asia to U.S. ports, establish colonies, and expand their range.
A soon-to-be-published article in the Entomological Society of America's journal, Insect Systematics and Diversity, promises to shed more light on the genus and the history of introductions in the United States. Kimsey and colleagues Allan Smith-Pardo of the USDA and James Carpenter of the America Museum of History, New York, co-authored the review article.
In the abstract, the authors define Vespa as social wasps that are “primarily predators of other insects, and some species are know to attack and feed on honey bees, Apis mellifera, which makes them a serious threat to apiculture.”
“Vespa nests can be physically large, with over 1,000 workers, but usually with hundreds of workers,” they wrote. “Nests can be aerial, attached to tree branches or in shrubs, in crevices, under eaves or underground depending on the species. Depending on the latitude, nests can be either annual, started by a new queen every spring, or perennial, where young queens take over from old ones. Colonies in warm tropical climates tend to be perennial.”
Washington State University Extension has published an AGH fact sheet, the work of the husband-wife team of Susan Cobey, bee breeder-geneticist and Timothy Lawrence, county director of Island County Extension (both formerly of UC Davis), and also Mike Jensen, county director of Pend Oreille. (See https://bit.ly/2SA3TxS)
The WSU scientists wrote that AGH “is the world's largest species of hornet, native to temperate and tropical Eastern Asia low mountains and forests. The hornet is well adapted to conditions in the Pacific Northwest.”
“The primary purpose of venom is defense against predators by inflicting pain and damage,” they wrote. ”Vespa mandarinia is one of the two most venomous known insects in the world.. The amount of venom each wasp delivers (4.1 μl/ wasp) has designated V. mandarinia as the most venomous insect. In comparison, the honey bee has about 0.6μl/bee. When foraging for food in spring, the AGH is not highly defensive – unless its nest is disturbed. Late summer and fall, with the high demand for protein, they become very aggressive when attacking or occupying a honey bee colony.”
“It is critical that we identify, trap, and attempt to eliminate this new pest before it becomes established and widespread,” they wrote. “Attempts to contain the spread and eradication of this invasive insect will be most effective in trapping queens during early spring before their nests become established. Finding the nests can be a bit of a challenge. Their nests are typically in the ground though they can also be found under overhangs and within wall voids. The AGH is a strong flier and often will fly up and away and have an extensive flight range. Thus tracking can be difficult.”
They advise residents to “proceed with extreme caution and contact WSDA immediately. Do not try to exterminate the nest yourself.”
Cobey, who examined specimens in Japan last December and shipped some to WSU, commented this week that “I see they have already taken on the media name, murder hornets."
The sensationalism on the media is a concern, said Lawrence, "but...we need to find out just how extensive this infestation is."
Facebook users are posting images of so-called Asian giant hornets that are actually such species as cicada killers, European hornets, southern yellow jacket queens, sawflies, hoverflies, a beetle, and a moth.
“Yes, it is possible this species could establish,” wrote parasitoid wasp specialist and educator Sloan Tomlinson. “Has it yet? No. Until concrete evidence is presented about any further establishment by this species, it's simply conjecture. Additionally, even IF this species is established, their infamy is overhyped and sensationalized. In Japan they do indeed kill around 30 people a year. Around 40 people are killed annually in the US by domestic dogs.”
Doctoral candidate and researcher Ellie Field of Iowa State University wrote on Facebook that “the murder hornet articles are making the rounds quickly and they seem to be doing more harm than good. Yes, it is awesome to track insect populations (particularly staying watchful for non-native and potentially invasive species). But no, the Asian giant hornet (Vespa mandarinia) is not going to destroy America. The one nest and individual that was found around Vancouver last year was destroyed, and this doesn't indicate any establishment. Introduction events happen all the time, all across the world! That region should continue to keep a watchful eye, but for everyone else this is not going to be relevant. There is no invasion, just a small possibility that some may have overwintered in that area.”
Those unsure about insect identification can email an image to Lynn Kimsey at firstname.lastname@example.org or contact the Entomological Society of America at https://www.entsoc.org/ or https://bit.ly/2W2jRmi.